Evidence map›Paper›PMID 39335209›Full record

ArticleCancers2024

Raman Spectroscopy for Instant Bladder Tumor Diagnosis: System Development and In Vivo Proof-Of-Principle Study in Accordance with the European Medical Device Regulation (MDR2017/745).

Ines Latka, Karin Mogensen, Florian Knorr, Cansu Kuzucu, Florian Windirsch, Dragan Sandic, Jürgen Popp, Gregers G Hermann, Iwan W Schie

Abstract read
In one paragraph

Article in Cancers, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ines LatkaLeibniz-Institute of Photonic Technology (IPHT), Leibniz-Health-Technologies, Leibniz-Center for Photonics in Infection Research (LPI), Albert-Einstein-Str. 9, 07745 Jena, Germany.ORCID 0009-0001-9367-6207
Karin MogensenUrology Department Herlev, Gentofte Hospital, Borgmester Ib Juuls vej 23A, DK-2730 Herlev/Copenhagen, Denmark.
Florian KnorrLeibniz-Institute of Photonic Technology (IPHT), Leibniz-Health-Technologies, Leibniz-Center for Photonics in Infection Research (LPI), Albert-Einstein-Str. 9, 07745 Jena, Germany.
Cansu Kuzucu2M Engineering, John F Kennedylaan 3, 5555XC Valkenswaard, The Netherlands.
Florian WindirschLeibniz-Institute of Photonic Technology (IPHT), Leibniz-Health-Technologies, Leibniz-Center for Photonics in Infection Research (LPI), Albert-Einstein-Str. 9, 07745 Jena, Germany.
Dragan SandicBlazejewski MEDI-TECH GmbH, Rheinstr. 1, 793650 Freiburg, Germany.
Jürgen PoppLeibniz-Institute of Photonic Technology (IPHT), Leibniz-Health-Technologies, Leibniz-Center for Photonics in Infection Research (LPI), Albert-Einstein-Str. 9, 07745 Jena, Germany.ORCID 0000-0003-4257-593X
Gregers G HermannUrology Department Herlev, Gentofte Hospital, Borgmester Ib Juuls vej 23A, DK-2730 Herlev/Copenhagen, Denmark.
Iwan W SchieLeibniz-Institute of Photonic Technology (IPHT), Leibniz-Health-Technologies, Leibniz-Center for Photonics in Infection Research (LPI), Albert-Einstein-Str. 9, 07745 Jena, Germany.

Funding

H2020-PHC-2015 GA 667933
6 · The paper itself

Abstract

This work reports on an in vivo Raman-based endoscopy system, invaScope, enabling Raman measurements of healthy and tumor bladder tissue during an endoscopic procedure in the operating theatre. The presented study outlines the progression from the initial concept (validated through previously performed ex vivo studies) to the approval and implementation of a clinical investigational device according to the requirement within the framework of the European Medical Device Regulation (MDR2017/745). The study's primary objective was to employ the invaScope Raman system within the bladder, capturing in vivo spectroscopic Raman data followed by standard histo- and cytopathological examinations of urological tissue (considered the gold standard). The collected data were analyzed and correlated with histopathological findings post-procedure. Additionally, the study aimed to assess the feasibility of using diagnostic equipment, probes, and software for application in a clinical setting, evaluating usability aspects that are important during surgical procedures. This research represents a pivotal step toward advancing Raman spectroscopy for routine clinical use in characterizing bladder lesions.

Indexed as

bladder cancerclinical studymedical device regulation (MDR)Raman spectroscopy

Identifiers

PMID39335209
PMCPMC11430582

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.